Perigon Wealth Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$397K	Sell	1,582 -449	-22%	-$112K	0.01%	907
2025 Q4	$559K	Buy	2,031 +423	+26%	+$116K	0.01%	741
2025 Q3	$422K	Buy	1,608 +422	+36%	+$103K	0.01%	811
2025 Q2	$259K	Sell	1,186 -497	-30%	-$106K	0.01%	897
2025 Q1	$377K	Sell	1,683 -25	-1%	-$6.89K	0.01%	729
2024 Q4	$576K	Sell	1,708 -42	-2%	-$13.2K	0.01%	595
2024 Q3	$525K	Buy	+1,750	New	+$536K	0.01%	606
2024 Q1	–	Sell	-1,863	Closed	-$656K	–	927
2023 Q4	$656K	Sell	1,863 -15	-0.8%	-$5.31K	0.02%	431
2023 Q3	$705K	Sell	1,878 -20	-1%	-$7.73K	0.03%	375
2023 Q2	$726K	Buy	1,898 +23	+1%	+$8.22K	0.03%	372
2023 Q1	$650K	Buy	1,875 +48	+3%	+$14K	0.04%	346
2022 Q4	$430K	Buy	+1,827	New	+$433K	0.03%	419
2022 Q2	–	Sell	-668	Closed	-$274K	–	628
2022 Q1	$274K	Buy	668 +156	+30%	+$61.1K	0.02%	489
2021 Q4	$240K	Buy	+512	New	+$220K	0.02%	510
2021 Q1	–	Sell	-95	Closed	-$27K	–	1042
2020 Q4	$27K	Buy	+95	New	+$26.7K	﹤0.01%	943